Cong Intl. Soc Vascular Behavioral & Cognitive Disorders

描述（由申请人提供）：在过去十年中，对包括阿尔茨海默病、血管性痴呆、轻度认知障碍、抑郁症和其他行为障碍在内的各种脑部疾病的血管原因的兴趣极大地增长。 中风、高血压、糖尿病和高脂血症都被证明是阿尔茨海默病的危险因素。 最近的证据还表明，阿尔茨海默病和血管性痴呆可以通过治疗高血压和高脂血症等血管危险因素来延迟甚至预防。 这些发现的潜在影响跨越了科学和临床兴趣的不同竞技场。 越来越明显的是，需要一个论坛来讨论和教育这些各种脑部疾病的血管原因。 这样一个论坛还将制定研究战略，以解决脑血管疾病的关键问题。 为此，国际血管行为和认知障碍学会（VAS-COG）第二届大会将汇集各种基础科学和临床研究兴趣，研究各种脑部疾病的血管原因，并作为传播这一信息，患者宣传和培训研究人员的工具。 我们将在第一次会议（哥德堡，2003年）成功的基础上再接再厉，这次会议聚集了636名与会者（其中225名是妇女），传播关于各种脑部疾病的血管原因的知识，包括阿尔茨海默病、血管性痴呆、轻度认知障碍、抑郁症和其他行为障碍。 我们的第二次活动将在一个大型大会上介绍该领域的最新进展，包括国际公认的意见领袖的诊断和治疗进展。

DESCRIPTION (provided by applicant): Interest in the vascular causes of various brain disorders including Alzheimer's disease, vascular dementia, mild cognitive impairment, depression, and other behavioral disorders has grown immensely over the last decade. Stroke, hypertension, diabetes and hyperlipidemia have all been shown to be risk factors for Alzheimer's disease. Recent evidence also suggests that Alzheimer's disease and vascular dementia may be delayed or even prevented by treatment of vascular risk factors such as hypertension and hyperlipidemia. The potential implications of these findings span a diverse arena of both scientific and clinical interest. It is increasingly apparent that a forum for discussion and education on vascular causes of these various brain disorders is needed. Such a forum would also develop research strategies to address key issues in cerebrovascular diseases. To this end, the Second Congress of the International Society for Vascular Behavioral and Cognitive Disorders (VAS-COG) will bring diverse basic science and clinical research interest together for the study of vascular causes of various brain disorders, as well as to serve as a vehicle for the dissemination of this information, patient advocacy and training of researchers. We will build upon the success of our first meeting (Goteborg, 2003) at which 636 participants (out of which 225 were women) were brought together to disseminate knowledge on vascular causes of various brain disorders, including Alzheimer's disease, vascular dementia, mild cognitive impairment, depression, and other behavioral disorders. Our second event will present in one large Congress the most recent advances in the field, including diagnostic and therapeutic developments by internationally recognized opinion leaders.